<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Xlsx>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE271nnn/GSE271179/suppl/GSE271179_NormalizedCounts_edgeR.xlsx</Xlsx><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE271nnn/GSE271179/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271179</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Transcriptome analysis of cell line/patient-derived xenograft (PDX) samples of myeloid leukemia associated with Down syndrome (ML-DS)</name><description>Myeloid leukemia associated with Down syndrome (ML-DS) is a rare pediatric cancer in which 10-20% patients who are relapsed/refractory have very limited treatment options. Novel treatment options may be identified via transcriptome profiling.</description><dates><publication>2026/06/18</publication></dates><accession>GSE271179</accession><cross_references><GSM>GSM8371427</GSM><GSM>GSM8371426</GSM><GSM>GSM8371436</GSM><GSM>GSM8371425</GSM><GSM>GSM8371424</GSM><GSM>GSM8371435</GSM><GSM>GSM8371419</GSM><GSM>GSM8371429</GSM><GSM>GSM8371428</GSM><GSM>GSM8371430</GSM><GSM>GSM8371434</GSM><GSM>GSM8371423</GSM><GSM>GSM8371422</GSM><GSM>GSM8371433</GSM><GSM>GSM8371432</GSM><GSM>GSM8371421</GSM><GSM>GSM8371431</GSM><GSM>GSM8371420</GSM><GPL>11154</GPL><GSE>271179</GSE><taxon>Homo sapiens</taxon><PMID>[41945753]</PMID></cross_references></HashMap>